The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece

Mediterranean Journal of Rheumatology

ARTICLE

Evangelos Theotikos¹  Ioannis Raftakis¹  Antonia Elezoglou¹  Christodoulos Antoniadis¹ 

[1] Asklipeion General Hospital of Voula

关键词: Gout;    Canakinumab;    Uric Acid;    Patients;   

DOI  :  10.31138/mjr.28.1.48

学科分类：社会科学、人文和艺术（综合）

来源: PCO Convin S.A.

【 摘 要 】

Gout is an autoinflammatory disease caused by monosodium urate mono hydrate crystal deposition in tissues or the supersaturation of extracellular fluids of uric acid. In this study, we are going to report the experience of the Asklepeion Voula Rheumatology Clinic, treating four patients with gouty arthritis who received Canakinumab.

【 授权许可】

CC BY-NC